Background illustration for clinical trials search

Paid Clinical Trials Boca Raton

Discover 1,971 paid clinical trials in Boca Raton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,971

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

for

Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer

Location: Miami FL, Orlando FL, Tampa FL, Washington D.C. DC,

Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05208047

Phase3, Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for

Unresectable Melanoma, Metastatic Melanoma,

Location: Miami FL, Orlando FL, Tampa FL, Louisville KY,

Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase1, Phase2, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for

Neovascular Age-Related Macular Degeneration (nAMD)

Location: Stuart FL, Orlando FL, Tampa FL, St. Petersburg FL,

Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

for

Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases

Location: Miami FL, Bay Pines FL, Gainesville FL, Jacksonville FL,

Sponsor: Duke University

Sex: All

Age: 70+

Code: NCT04262206

Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for

Atopic Dermatitis

Location: Miami FL, St. Petersburg FL, Macon GA, Atlanta GA,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for

Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma

Location: Aventura FL, Hialeah FL, Margate FL, Gainesville FL,

Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for

Superficial Bladder Cancer,

Location: Miami FL, Jacksonville FL, Augusta GA, Myrtle Beach SC,

Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

for

HIV Infections

Location: Miami FL

Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06730555

Recruiting

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

for

Ulcerative Colitis

Location: Lighthouse PT FL, Miami FL, Palmetto Bay FL,

Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06975722

Phase2, Recruiting

Immune Reconstitution in Stem Cell Transplant Recipients

for

Cancer

Location: Miami FL

Sponsor: University of Miami

Sex: All

Age: 18 - 70+

Code: NCT02129543

Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for

Advanced Solid Tumor

Location: Miami FL, Celebration FL, Charleston SC, Denver CO,

Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase1, Phase2, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for

Peripheral T-Cell Lymphoma, Not Otherwise Specified,

Location: Miami FL, Atlanta GA, Chapel Hill NC, Baltimore MD,

Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for

Ovarian Cancer, Fallopian Tube Cancer,

Location: Miami FL, Orlando FL, Tampa FL, Jacksonville FL,

Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase2, Recruiting

ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

for

Non Small Cell Lung Cancer

Location: Miami FL

Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06902272

Phase2, Recruiting

Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS

for

Acute Myelogenous Leukemia, Myelodysplastic Syndromes

Location: Miami FL, Gainesville FL, Westwood KS, Los Angeles CA

Sponsor: Mateon Therapeutics

Sex: All

Age: 18+

Code: NCT02576301

Phase1, Phase2, Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

for

T-cell Lymphoma, T-cell Leukemia

Location: Miami FL, Houston TX, Indianapolis IN, New York NY

Sponsor: Huda Salman

Sex: All

Age: 12+

Code: NCT03829540

Phase1, Recruiting

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

for

Carcinoma, Squamous Cell

Location: Miami FL, Columbia SC, Louisville KY, Baltimore MD,

Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041626

Phase3, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

for

Plaque Psoriasis

Location: Miami FL

Sponsor: Ascletis Pharma (China) Co., Limited

Sex: All

Age: 18 - 65

Code: NCT07024602

Phase1, Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

for

Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma,

Location: Miami FL, Huntersville NC, Nashville TN, Houston TX,

Sponsor: Aulos Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05267626

Phase1, Phase2, Recruiting

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

for

Prostatic Neoplasms, Castration-Resistant

Location: Miami FL, Cleveland OH, Milwaukee WI, Montreal, Quebec,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06353386

Phase1, Phase2, Recruiting

Paid Clinical Trials Boca Raton

Filter results

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Interested in new trials?

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Immune Reconstitution in Stem Cell Transplant Recipients

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS

CD4CAR for CD4+ Leukemia and Lymphoma

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)